08:51 AM EDT, 05/23/2024 (MT Newswires) -- TFF Pharmaceuticals ( TFFP ) said Thursday that the government would advance several next-generation medical countermeasures formulated with its thin-film freezing, or TFF, technology into advanced preclinical testing.

The clinical-stage company said it is working with US defense contractor Leidos Holdings ( LDOS ) to develop these medical countermeasures designed to protect military and healthcare personnel from future chemical and biological threats.

The research is funded by the Defense Advanced Research Projects Agency.

Price: 2.2696, Change: +0.08, Percent Change: +3.63